全球合成生物学市场规模、份额、趋势和成长分析报告（2026-2034）

预计合成生物学市场将从 2025 年的 192.9 亿美元成长到 2034 年的 843.1 亿美元，2026 年至 2034 年的复合年增长率为 17.81%。

基因工程和生物技术的进步正推动全球合成生物学市场显着扩张。合成生物学能够设计用于医疗保健、农业和工业应用的客製化生物系统。研发投入的增加和对创新治疗方法的需求正在支撑市场的快速成长。生物基产品的不断开发也进一步推动了该产业的成长。

成长要素包括对基因编辑技术和生物製造解决方案日益增长的需求。疫苗研发和可再生化学品领域的应用支撑着稳定的需求。研究机构与生技公司之间的合作正在加速创新。此外，政府的支持性资金也促进了研究活动。

基因组编辑技术的持续进步使未来前景极为光明。永续生物基材料和燃料的开发将创造新的机会。人工智慧与生物设计的融合将提高效率。随着科技的进步，市场预计将迎来强劲成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球合成生物学市场：依产品划分

• 市场分析、洞察与预测
• 寡核苷酸/寡核苷酸丛集和合成DNA
• 酵素
• 克隆技术套件
• 异种核酸
• 基本生物

第五章 全球合成生物学市场：依技术划分

• 市场分析、洞察与预测
• 次世代定序技术
• PCR技术
• 基因组编辑技术
• 生物加工技术
• 其他技术

第六章 全球合成生物学市场：依应用领域划分

• 市场分析、洞察与预测
• 卫生保健
• 非医疗保健产业

第七章 全球合成生物学市场：依最终用途划分

• 市场分析、洞察与预测
• 生物技术和製药公司
• 学术研究机构
• 其他的

第八章 全球合成生物学市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 亚太其他地区
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Bota Biosciences Inc
  • Codexis Inc
  • Creative Biogene
  • Creative Enzymes
  • Enbiotix Inc
  • Illumina Inc
  • Merck KGaA（Sigma-Aldrich Co. LLC）
  • New England Biolabs
  • Eurofins Scientific
  • Novozymes
  • Pareto Bio Inc

The Synthetic Biology Market size is expected to reach USD 84.31 Billion in 2034 from USD 19.29 Billion (2025) growing at a CAGR of 17.81% during 2026-2034.

The Global Synthetic Biology market has expanded significantly due to advancements in genetic engineering and biotechnology. Synthetic biology enables the design of customized biological systems for healthcare, agriculture, and industrial applications. Increasing research investments and demand for innovative therapies have supported rapid market growth. Expanding bio-based product development further strengthens industry expansion.

Growth drivers include rising demand for gene editing technologies and bio-manufacturing solutions. Applications in vaccine development and renewable chemicals contribute to steady demand. Collaboration between research institutions and biotechnology companies accelerates innovation. Additionally, supportive government funding enhances research activities.

Future prospects remain highly promising as breakthroughs in genome editing continue. Development of sustainable bio-based materials and fuels will create new opportunities. Integration of artificial intelligence in biological design will enhance efficiency. The market is projected to grow robustly alongside scientific advancements.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Oligonucleotide/Oligo Pools And Synthetic DNA
• Enzymes
• Cloning Technologies Kits
• Xeno-Nucleic Acids
• Chassis Organism

By Technology

• Ngs Technology
• Pcr Technology
• Genome Editing Technology
• Bioprocessing Technology
• Other Technologies

By Application

• Healthcare
• Non-Healthcare

By End Use

• Biotechnology And Pharmaceutical Companies
• Academic And Research Institutes
• Others

COMPANIES PROFILED

• Bota Biosciences Inc, Codexis Inc, Creative Biogene, Creative Enzymes, Enbiotix Inc, Illumina Inc, Merck KGaA SigmaAldrich Co LLC, New England Biolabs, Eurofins Scientific, Novozymes, Pareto Bio Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SYNTHETIC BIOLOGY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Oligonucleotide/Oligo Pools And Synthetic DNA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Enzymes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cloning Technologies Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Xeno-Nucleic Acids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Chassis Organism Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SYNTHETIC BIOLOGY MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Ngs Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pcr Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Genome Editing Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Bioprocessing Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SYNTHETIC BIOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Non-Healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SYNTHETIC BIOLOGY MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Biotechnology And Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SYNTHETIC BIOLOGY MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Technology
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Technology
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Technology
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Technology
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Technology
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL SYNTHETIC BIOLOGY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Bota Biosciences Inc
  • 10.2.2 Codexis Inc
  • 10.2.3 Creative Biogene
  • 10.2.4 Creative Enzymes
  • 10.2.5 Enbiotix Inc
  • 10.2.6 Illumina Inc
  • 10.2.7 Merck KGaA (Sigma-Aldrich Co. LLC)
  • 10.2.8 New England Biolabs
  • 10.2.9 Eurofins Scientific
  • 10.2.10 Novozymes
  • 10.2.11 Pareto Bio Inc